Laurus Labs Ltd. header image

Laurus Labs Ltd.

540222

Equity

ISIN INE947Q01028 / Valor 56464789

Bombay Stock Exchange Ltd. (Mumbai) (2026-07-03)
INR 1,541.75+1.09%

Laurus Labs Ltd.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Originally incorporated on 19 September 2005 as Laurus Labs Private Limited and converted to a public limited company in February 2007, Laurus Labs Limited is a Hyderabad-based fully integrated pharmaceutical and biotechnology company founded by Satyanarayana Chava. The company develops, manufactures and sells APIs (anti-retrovirals, anti-diabetics, cardiovascular, oncology, hepatitis C), generic oral solid formulations, CDMO services, nutraceutical specialty ingredients, and biotechnology solutions (enzymes, biopharma proteins). It operates eight manufacturing plants in Visakhapatnam, Hyderabad and Bengaluru, with regulatory approvals from USFDA, WHO, MHRA, TGA and PMDA.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

103%1Y
332%3Y
127%5Y

Performance

29.3%1Y
32.4%3Y
33.2%5Y

Volatility

Market cap

8724 M

Market cap (USD)

Daily traded volume (Shares)

177,157

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.37%USD 33.47
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.44%USD 25.39
Sareum Holdings PLC
Sareum Holdings PLC Sareum Holdings PLC Valor: 116566624
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 0.21
Shield Therapeutics PLC
Shield Therapeutics PLC Shield Therapeutics PLC Valor: 29778101
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.65%GBP 0.061
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%INR 822.60
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.83%USD 45.14
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd Cohance Lifesciences Ltd Valor: 46346459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.62%INR 454.85
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.10%USD 9.20
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.29%USD 19.64
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.69%EUR 0.96